Author

Elizabeth Guo

2015-2016 Peter Barton Hutt Student Fellow During her fellowship year, Elizabeth Guo was a third year student in the JD/MPH Program at Harvard Law School and the Harvard School of Public Health. Her interests lie at the intersection of law, health care reimbursement, and biopharmaceutical regulation. Elizabeth graduated from Harvard University with a BA in social studies, focusing on the bioethics of assisted reproduction in China. Prior to law school, she was a senior associate at Avalere Health working with life science clients on a range of health policy topics, including Medicare coverage and reimbursement, biosimilar regulation, and healthcare quality programs. Elizabeth served as a student editor of the Journal of Law and Technology and a member of the Mississippi Delta Project’s Delta Project’s Food Policy Initiative. Elizabeth’s fellowship paper was entitled: “Reputation and Judicial Deference: An Examination of FDA’s Reputation and Judicial Deference to Agency Action.”
  • Health Law Policy

    Medicare Coverage for Sex Change Surgery: How We Got Here

    By Elizabeth Guo As mentioned in co-blogger Matthew Lawrence‘s prior posts (here) and (here), Medicare’s Departmental Appeals Board (DAB) recently vacated a decades-old National Coverage Determination (NCD) precluding coverage for sex change therapy.  That opens the door…

    Medicare Coverage for Sex Change Surgery: How We Got Here

  • Health Law Policy

    Medicare Coverage for Sex Change Therapy: What’s Next

    By Matthew Lawrence and Elizabeth Guo Last month Medicare’s policy on coverage for sex change therapy changed somewhat. (See Matt’s earlier post here.) Specifically, Medicare’s Departmental Appeals Board invalidated the long-standing National Coverage Determination that…

    Medicare Coverage for Sex Change Therapy: What’s Next